rosiglitazone has been researched along with Kidney Calculi in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Chen, X; Jia, M; Jiang, K; Lu, H; Sun, F; Sun, X; Zhu, J | 1 |
1 other study(ies) available for rosiglitazone and Kidney Calculi
| Article | Year |
|---|---|
Rosiglitazone Suppresses Renal Crystal Deposition by Ameliorating Tubular Injury Resulted from Oxidative Stress and Inflammatory Response via Promoting the Nrf2/HO-1 Pathway and Shifting Macrophage Polarization.
Topics: Animals; Hypoglycemic Agents; Kidney Calculi; Male; Mice; Nephrolithiasis; NF-E2-Related Factor 2; Oxidative Stress; Rosiglitazone; Signal Transduction | 2021 |